South Korea’s Naver Corp and Kakao Corp revealed their innovative use of AI in healthcare at the HIMSS24 APAC panel. Kakao Healthcare is using AI and machine learning to optimise clinical data, reducing resources by up to 80%. Naver’s newly launched symptom checker integrates patients’ medical history with their EMR, saving time for both patients and doctors. The tool also includes doctor-made notes, reducing cognitive burden for physicians.
Wall Street’s Leaders and Laggards of 2024
2024 was a mixed year for biopharma stocks, with the iShares Biotechnology ETF and SPDR S&P Biotech ETF experiencing small decreases. Federal Reserve decisions caused
